News

September 7, 2023

Prescience Point Capital Management Reiterates “Strong Buy” Recommendation on AerSale Corporation with Price Target of $45.90

FAA Approval and Commercialization of AerAware, and Reacceleration of Growth in Core Business are Powerful Catalysts for Immediate Share Price Appreciation Recent, Large Insider Purchases…

May 31, 2022

Prescience Point Capital Management Releases Presentation Detailing Board And Management Failures at MiMedx Group

May 6, 2022

Prescience Point To WITHHOLD Votes for MiMedx Directors and Vote AGAINST the Advisory Approval of Executive Compensation

BATON ROUGE, La., May 6, 2022 —  Prescience Point Capital Management LLC (“Prescience Point”), a research-focused, catalyst-driven investment firm that beneficially owns approximately 6.7% of…

November 15, 2018

Institutional Investor Magazine Profiles Eiad Asbahi

Institutional Investor Magazine sat down with our founder Eiad Asbahi for a wide ranging profile on the firm’s strategy, history and latest short idea (Link…

Barron's · February 1, 2022

Barron’s Reports on Prescience Point’s Bullish Groupon Research

Barron's article on Groupon, Inc. quotes Prescience Point's bullish research report, which it says was responsible for "fueling the rally" in the stock. ...

May 4, 2021

Prescience Point’s Slide Presentation on MiMedx Group (MDXG)

April 16, 2021

Prescience Point Launches Proxy Fight at MiMedx

Prescience Point Capital Management, together with its affiliates (“Prescience Point”), a research-focused, catalyst-driven investment firm, announced today the nomination of four highly qualified director candidates…

Businss Insider · December 11, 2019

Business Insider: The short-seller who predicted Celadon’s implosion explains what tipped him off

...

December 6, 2019

Reuters: Two ex-Celadon executives charged with fraud at trucking company

Two former top executives at Celadon Group Inc have been charged with fraud and lying to auditors by concealing losses in the trucking company’s aging…

November 27, 2019

Bloomberg: MiMedx Indictments Could Mean the Worst Is Over

According to prosecutors, MiMedx reported revenue of $187.3 million in 2015. The alleged fraudulent activity accounted for just $9.5 million of that amount. One suspects…